Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Search with the first character of the name of the medicinal product: l


Summaries of Product Characteristics 1 - 30 of 272
  1  2  3  4  5  6  7  8  9  10  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

PL

Resepti

Labetalol S.A.L.F. 5 mg-ml injektio-infuusioneste, liuos SPC 2022-01-17

European Medicines Agency's website:
Lacosamide Accord - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Lacosamide Medical Valley 10 mg-ml siirappi SPC 2022-02-14

PL

Resepti

Lacosamide Medical Valley 50 mg, 100 mg, 150 mg, 200 mg tabletti, kalvopäällysteinen SPC 2022-02-14

PL

Resepti

Lacosamide Stada 50 mg, 100 mg, 150 mg, 200 mg tabletti, kalvopäällysteinen SPC 2021-10-14

European Medicines Agency's website:
Lacosamide UCB - EMA: EPAR PI
Finnish Swedish

PL

Itsehoito

Lactulos ratiopharm 667 mg-ml oraaliliuos SPC 2022-04-22

PL

Itsehoito

Lactulose-MIP 650 mg-ml oraaliliuos SPC 2022-04-04 Uusi

PL

Itsehoito

Ladiva kapseli, kova SPC 2021-11-12

PL

Itsehoito

Laktufarm (ent. Levolac) 670 mg-ml oraaliliuos SPC 2022-07-19 Uusi

PL

Resepti

Lamictal 2 mg, 5 mg, 25 mg, 50 mg, 100 mg, 200 mg purutabletti-dispergoituva tabletti SPC 2022-06-22

PL

Resepti

Lamictal 2 mg, 5 mg, 25 mg, 50 mg, 100 mg, 200 mg purutabletti-dispergoituva tabletti SPC 2022-06-22

PL

Resepti/itsehoito

Lamisil 1 prosenttinen emulsiovoide SPC 2021-10-12

PL

Resepti

Lamisil 1-prosenttinen liuos iholle SPC 2021-07-09

PL

Resepti/itsehoito

Lamisil 1-prosenttinen sumute iholle, liuos SPC 2021-07-09

PL

Resepti/itsehoito

Lamisil DermGel 1 prosenttinen geeli SPC 2021-08-27

PL

Itsehoito

Lamisil Solo 1 prosenttinen liuos iholle SPC 2021-04-28

European Medicines Agency's website:
Lamivudine Teva - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Lamivudine Teva Pharma B.V. - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Lamivudine-Zidovudine Accord 150 mg-300 mg tabletti, kalvopäällysteinen SPC 2022-07-12 Uusi

European Medicines Agency's website:
Lamivudine/Zidovudine Teva - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Lamostad 5, 25, 50, 100, 200 mg dispergoituva tabletti SPC 2005-09-01

PL

Resepti

Lamotrigin Orion 25 mg, 50 mg, 100 mg, 200 mg dispergoituva tabletti SPC 2022-06-16 Uusi

PL

Resepti

Lamotrigin ratiopharm 25 mg, 50 mg, 100 mg, 200 mg dispergoituva tabletti SPC 2022-05-10

European Medicines Agency's website:
Lamzede - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Lansoprazoi Cobin 15 mg, 30 mg enterokapseli SPC 2009-01-23

PL

Resepti

Lansoprazoi Lichte 15 mg, 30 mg enterokapseli SPC 2009-01-23

PL

Resepti

Lansoprazol Krka 15 mg, 30 mg enterokapseli, kova SPC 2022-05-17

PL

Resepti

Lansoprazol Uka 15 mg, 30 mg enterokapseli SPC 2009-01-23

PL

Resepti

Lansoprazole Hexal 15 mg, 30 mg enterokapseli, kova SPC 2021-03-10

  1  2  3  4  5  6  7  8  9  10  |  Next 30   >